4Front Ventures Corp Stock Price, News & Analysis

4Front Ventures Corp. (CSE: FFNT, OTCQX: FFNTF) announced participation in Needham's 24th Annual Virtual Growth Conference from January 10-14, 2022. Andrew Thut, Chief Investment Officer and Interim Chief Financial Officer, will speak on January 14 at 12:30 PM ET. The company plans to conduct small group and one-on-one meetings with investors throughout the event. 4Front is a multi-state cannabis operator with a reputation for low-cost cultivation and production, managing operations in key markets including California, Illinois, Michigan, and Washington.

4Front Ventures Corp. (CSE: FFNT) reported its Q3 2021 financial results, showcasing a 48% year-over-year increase in systemwide pro forma revenue to $33.1 million. GAAP revenue rose 70% to $25.9 million, but both metrics declined 4% sequentially. Adjusted EBITDA soared 103% to $7.5 million, maintaining a margin of 23%. The company initiated construction of a 558,000 sq. ft. facility in Illinois and opened its 170,000 sq. ft. manufacturing site in California. A proposed acquisition of New England Cannabis Corporation aims to enhance its Massachusetts presence, targeting significant long-term revenue opportunities.

4Front Ventures Corp (CSE: FFNT, OTCQX: FFNTF) will release its third-quarter financial results for the period ending September 30, 2021, on November 17, 2021, after market close. Following the report, a conference call is scheduled at 5:00 p.m. Eastern Time to discuss the outcomes and current business trends. 4Front Ventures operates in key cannabis markets, including California and Massachusetts, and boasts a portfolio of over 20 cannabis brands and 1800 products. The company aims to enhance shareholder value with its extensive industry expertise.

4Front Ventures Corp has received its business license for a new 170,000 sq. ft. cannabis manufacturing facility in Commerce, California. This facility, among the largest globally, will produce nine of 4Front's brands and 164 different SKUs, utilizing advanced automation and technologies. It aims to produce significantly more than its other facilities, with a distribution partnership with Nabis. This operational milestone aligns with 4Front's recent agreement to acquire New England Cannabis Corporation, strengthening its market presence in California and Massachusetts.

4Front Ventures Corp. (CSE: FFNT, OTCQX: FFNTF) announced its agreement to acquire New England Cannabis Corporation (NECC) for a total consideration of US$55 million. This acquisition is expected to significantly boost 4Front's EBITDA for 2022 and enhance its market share in the growing Massachusetts cannabis market. The deal will more than double 4Front's total flower canopy and expand processing capabilities. The cash portion of the deal is financed through a US$15 million convertible note offering. The closing of the transaction is subject to regulatory approval.

4Front Ventures Corp (CSE: FFNT, OTCQX: FFNTF), a leading multi-state cannabis operator, announced its participation in several upcoming investor conferences. Key events include the Needham Cannabis Conference on September 14, 2021, where the management will present at 1:30 PM ET, and the BTIG's Inaugural Cannabis Conference on September 29, 2021, featuring a fireside chat with CIO Andrew Thut at 4:00 PM ET. Additionally, they will attend the Benzinga Cannabis Capital Conference on October 13-14, 2021. Interested investors can reach out at IR@4frontventures.com.

4Front Ventures reported Q2 2021 Systemwide Pro Forma Revenue of $34.4 million, a notable 85% increase year-over-year and 10% sequentially. The company achieved an Adjusted EBITDA of $7.5 million, marking a 27% increase from Q1 2021, with an Adjusted EBITDA margin of 22%. 4Front reiterated its FY2021 guidance of $170-180 million in revenue and $40-50 million in EBITDA. Navy Capital will lead financing for an upcoming acquisition aimed at enhancing market presence. The company plans to open its third dispensary in Massachusetts on August 21, 2021.

4Front Ventures Corp has received a commencement letter from the Massachusetts Cannabis Control Commission, allowing it to open its third dispensary, Mission Brookline, on August 21 at 10 am. This new location, situated in the Allston Innovation Corridor, will serve adults 21 and older by appointment only. The company aims to provide a wide range of cannabis products, leveraging its established brands and retail expertise. With existing dispensaries in Georgetown and Worcester, 4Front is poised to enhance its market presence in Massachusetts.